|
Product class:
|
Medicinal product with marketing authorization
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Name of medicinal product:
|
Pergoquin
|
|
Active substances:
|
|
|
ATC code:
|
QN04BC02
|
|
Dosage form:
|
tablet
|
|
Strength:
|
1mg
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Summary of product characteristics (SPC):
|
 (last updated September 27, 2023)
|
|
Package information leaflet (PIL):
|
EST (last updated September 27, 2023)
|
|
Labelling:
|
(last updated September 27, 2023)
|
|
Indication:
|
Symptomatic treatment of clinical signs associated with Pituitary Pars Intermedia Dysfunction (PPID) (Equine Cushing’s Disease).
|
|
Safety features:
|
No
|
|
Marketing authorization holder:
|
Vetviva Richter GmbH
|
|
Marketing authorization number:
|
2202
|
|
Marketing authorization issued on:
|
September 24, 2019
|
|
Marketing authorization expires on:
|
September 24, 2024
|
|
Marketing authorization procedure type:
|
Decentralised
|
|
Assessment report:
|
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
|
1782682
|
Pergoquin
|
tablet
|
1mg 50TK
|
Prescription
|
|
|
|
|
|
|
1782693
|
Pergoquin
|
tablet
|
1mg 60TK
|
Prescription
|
|
|
27.03.2023
|
|
|
|
1782705
|
Pergoquin
|
tablet
|
1mg 100TK
|
Prescription
|
|
|
|
|
|
|
1782716
|
Pergoquin
|
tablet
|
1mg 150TK
|
Prescription
|
|
|
|
|
|
|
1782727
|
Pergoquin
|
tablet
|
1mg 160TK
|
Prescription
|
|
|
|
|
|
|
1782738
|
Pergoquin
|
tablet
|
1mg 200TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere